---
schema_version: "secwatch.filing_event.v1"
accession: "0001159036-25-000068"
form_type: "8-K"
ticker: "HALO"
cik: "0001159036"
company_name: "HALOZYME THERAPEUTICS, INC."
filed_at: "2025-12-08T23:59:59+00:00"
generated_at: "2026-05-16T13:55:30.075645+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Halozyme elects James Lang to Board of Directors, term through 2027 annual meeting

## Summary
- James Lang elected to Halozyme's Board on December 4, 2025.
- Mr. Lang's term expires at the 2027 annual meeting of stockholders.
- No Board committee assignments initially made.
- Compensation follows standard non-employee director program as described in the 2025 proxy.
- No related party transactions or arrangements exist with Mr. Lang.

## SEC filing metadata
- accession: 0001159036-25-000068
- form_type: 8-K
- ticker: HALO
- cik: 0001159036
- company_name: HALOZYME THERAPEUTICS, INC.
- filed_at: 2025-12-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1159036/000115903625000068/0001159036-25-000068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1159036/000115903625000068/halo-20251204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001159036-25-000068
- JSON: https://secwatch.observer/filing/0001159036-25-000068.json
- Plain text: https://secwatch.observer/filing/0001159036-25-000068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.